HU
Hospital Universitario de Burgos at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Hospital Universitario de Burgos brings 4 presentations to IDWeek 2026 in Washington. Its program centres on long-acting cabotegravir plus rilpivirine in routine HIV care, drawing on real-world data from the Spanish RELATIVITY cohort. It covers durability and adherence over time, switching without past genotype results, and outcomes in people with obesity.
| Organization | IDWeek 2026 Attendance |
|---|---|
HU Hospital Universitario de Burgos Burgos, Spain | |
Poster Fri Oct 23 12:15pm–1:30pm Long-Term Durability and Virological Effectiveness of Long-Acting Cabotegravir plus Rilpivirine in Routine HIV Care: Updated Real-World Data from the Spanish RELATIVITY Cohort Poster Fri Oct 23 12:15pm–1:30pm Longitudinal Adherence to Long-Acting Cabotegravir plus Rilpivirine in Routine Clinical Practice: Updated Temporal Trends from the RELATIVITY Cohort in Spain Poster Fri Oct 23 12:15pm–1:30pm Switching to Long-Acting Cabotegravir and Rilpivirine Without Historical Genotyping Availability: Effectiveness and Durability from the RELATIVITY Cohort Talk Fri Oct 23 2:33pm–2:45pm Long-Acting Cabotegravir Plus Rilpivirine in People With HIV With Obesity (BMI ≥30 kg/m²): High Durability With Distinct Discontinuation Patterns HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship |
Instantly find 20 buyers from Hospital Universitario de Burgos
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction